IVF News & Events

INVO Fertility issued a shareholder letter from its Chief Executive Officer, Steve Shum, outlining the Company's strengthened fundamental position and its strategic outlook for continued growth. "As we reflect on the progress of INVO Fertility and look ahead to the opportunities before us, we believe our company is in the strongest fundamental position in its history... Over the past several years, our team has worked deliberately to stabilize the business, strengthen the balance sheet, and build a scalable clinical platform capable of sustainable growth... At the core of our progress is the strength of our operating platform. INVO Fertility now has three operational fertility clinics, creating positive operational cash flow and demonstrating the effectiveness of our clinical, operational, and patient-centric model... In addition to our existing footprint, we are nearing the closing on the acquisition of our fourth clinic in Indianapolis... Before factoring in additional organic growth-which we expect to achieve this year-the combined pro forma annualized revenue run rate from all clinics, including both consolidated and equity method clinics, is approximately $9 million inclusive of Indianapolis... Organic growth remains a central component of our strategy... Looking ahead, we anticipate strong growth in 2026, driven by a combination of acquisitions and continued organic expansion... During the past year, we took important steps to simplify and strengthen our capital structure... We believe we are now well positioned to execute our growth objectives this year, without compromising financial discipline. Our focus remains on building a durable, scalable platform that can support sustained growth over time... As we look to the future, we are optimistic about what lies ahead. With a strong operational foundation, a growing clinic network, a robust acquisition pipeline, and the strongest balance sheet we have had in years, INVO Fertility is well positioned for the next chapter of its growth."

INVO Fertility files to sell 9.47M shares of common stock for holders

INVO Fertility announced changes to its executive leadership team. Terah Krigsvold, who has served as INVO's controller since December 2020, has been appointed as the company's new chief financial officer, replacing Andrea Goren. Goren, who has served as INVO chief financial officer since July 2021, has been appointed as chief business officer, as well as chief executive officer of INVO Centers LLC, the company's wholly owned subsidiary focused on fertility clinics. "As we continue to grow our presence in the fertility sector and based on Terah and Andrea's commitment, hard work and growth over the past five years, this realignment of roles strengthens our ability to execute our plan to grow the business and reach profitability," said Steve Shum, CEO of INVO. "I have worked with Terah for the past seven years and am thrilled at the progress she has demonstrated over that time. This promotion is very well deserved and ensures continuity, as well as keeping our finance and accounting functions in a strong pair of hands. With this change, Andrea is now able to focus more of his time on leading the execution of our primary growth strategy, acquisitions, and, in due course, new clinic launches. Andrea has worked on approximately $1 billion of financing and acquisition transactions in his career and is ideally suited to manage the negotiations and complex legal and diligence aspects of our acquisition and new clinic efforts. Andrea also will continue in his roles of managing our legal function and supporting our investor, shareholder, and related activities."

INVO Fertility files to sell 7.37M shares of common stock for holders